Navigation Links
Frost & Sullivan Recognizes CRi for Innovations Leading to Personalized Medicine
Date:4/13/2009

SAN FRANCISCO, April 13 /PRNewswire/ -- Cambridge Research & Instrumentation, Inc. (CRi) was presented with Frost & Sullivan's United States Optical Imaging Technologies in Drug Discovery Product Line Strategy Award at the 2009 Excellence in Medical Technologies & Life Sciences award banquet.

The Award recognizes CRi's product development strategy for the in-vitro and in-vivo imaging markets, achieved by creating innovative solutions that address a wide range of unmet needs in life sciences applications. The company's Nuance(TM) and Maestro(TM) multispectral solutions enable researchers and clinicians to quantitatively analyze multiple molecular markers in single cells, in tissues, and in whole organisms, aiding in the understanding the behavior of signaling pathways. Such knowledge is essential for guiding drug development and clinical trials designs.

"By facilitating the analysis of complex biological systems, our solutions are helping our customers build the foundation for personalized medicine," said George Abe, President and CEO of CRi. "It is very rewarding that the technical and strategic approach being taken by the team at CRi is being further recognized with such an award."

CRi recently introduced inForm(TM), an advanced image analysis program that employs machine learning technology to solve challenging image analysis problems. inForm combines a fast, easy to use learn-by-example image segmentation engine with powerful data analysis tools. Unlike conventional systems, the combination of Nuance and inForm can automatically identify and quantify relevant molecular expression patterns and signaling pathway data from clinically relevant cells and tissue regions.

CRi's image analysis software products automate, standardize, and simplify the complex and challenging tasks associated with measuring parameters and signals from associated molecular markers. Reliable data that refl
'/>"/>

SOURCE Cambridge Research and Instrumentation, Inc. (CRi)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Frost & Sullivan Honours LyondellBasell With Customer Value Enhancement Award
2. Rise in Sleeping Disorders Triggers High Demand for Sleep Service Facilities in Europe, Notes Frost & Sullivan
3. BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivans Product Innovation of the Year Award
4. Kenyan Pharmaceutical Industry Can Expect Significant Growth Despite Global Conditions, Finds Frost & Sullivan
5. Tough Recessionary Times, but Frost & Sullivan Believes Its Not All Gloomy for African Healthcare Markets
6. Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia
7. Frost & Sullivan: End-to-End Integration of HD Devices in the Operating Room Ushers in a New Era in Disruptive Technology
8. Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan
9. Frost & Sullivan Accolade for Ferring Pharmaceuticals
10. Leveraging the Third Amendment Ruling the Risk Management Process: Frost & Sullivans Assessment of Regulations for Medical Imaging Equipment in Europe
11. Frost & Sullivan Honours Outstanding Achievements in Healthcare

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...t study follow-up period was too short to draw def...NESDAY, Nov. 25 (HealthDay News) -- In diabetic pa...rs to be no difference in outcomes at one year whe...y with stenting, British researchers report. , ... diabetic patients with coronary artery disease. H...
(Date:11/25/2009)...rvivors often plagued by neurological symptoms, st...hDay News) -- Neurological side effects are among ...s of testicular cancer who were treated with cispl..., The study included 1,409 Norwegian men treated ...1994 who took part in a follow-up survey conducted...
(Date:11/25/2009)...,, LittleImprovementShownforthe4thStraightYea...-- Today,LungCancerAlliance-Georgia(LCA-GA)issued...nassessmentofprogressbeingmadeagainstthislethaldis...erAlliance(LCA),theonlynationalorganizationdedicat...ivingwithoratriskforlungcancer. ,, (Logo: http:...
(Date:11/25/2009)... mice, disks placed under the skin kill tumor cell...ealthDay News) -- A cancer vaccine delivered in a ... in mice, a new study reports. , The method use... are loaded with tumor-specific antigens and impla... to attack tumors. The Harvard University scientis...
(Date:11/25/2009)... BioSpace.com, the premier ... unveiled the third edition of the BioForest&trade... Englewood, CO (Vocus) November 25, 2009 -...nce careers and information, unveiled the third ed... morning., , , , ,This regional campaign is a pro...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...gear up for the Thanksgiving holiday, a new resear...( http://www.fasebj.org ), may provide some relief...he report, researchers describe a discovery that m... excess. Even more promising is that some of the a...
...pitals owned by Sutter Health and Daughters,of Cha...nited Healthcare Workers-West (UHW) are on strike ...s, five hospitals owned by Daughters of Charity,He... of the Sutter facilities, nurses who are part of ...
...SIVE AND INEFFECTIVE, NEW YORK, Oct. 29 "The NFL...d be using the most effective tool,to protect thei...says Betsy,McCaughey, Ph.D., Chairman of the not-f...ure that explains how,screening and other precauti...
...onal DVD and workshops, DETROIT, Oct. 29 Underst...he Medicare Annual Enrollment Period, Medicare,ben...verage and whether to,select different coverage op...nual decision. Thousands of beneficiaries also,wil...
...nnis is an excellent way to stay fit. But if you,r...ports can have unexpected long-term health risks. ...time occupational therapist and director of the Oc...uing amateur athletics during their leisure hours....
...North Carolina-based Oaks,Development Group announ...,at Pinnacles Park in Palm Coast, FL. Oaks will de...perty. SunTrust Bank in Cary, NC handled the loan,...,ownership model that provides tenants with a piec...
Other Medicine News:Health News:New drug target in obesity: Fat cells make lots of melanin 2Health News:United Healthcare Workers Stand Up For Patients in Statewide Hospital Strike 2Health News:Professional Sports Teams Should Use MRSA Screening and Other Aggressive Methods to Prevent Staph Infections 2Health News:Need Help Making Medicare Work for You? 2Health News:Play at your own risk 2Health News:Oaks Development Group Closes on 2.1 Acres for Medical Office Building in Palm Coast, FL 2Health News:Oaks Development Group Closes on 2.1 Acres for Medical Office Building in Palm Coast, FL 3
(Date:11/25/2009)...OHANNESBURG,November25/PRNewswire/--,iThembaPharma...dtoday,thattheyhavesignedacollaborativeagreementto...,sworldclasscomputationalchemistryandleaddiscovery...ntoprovidemedicinaland,syntheticchemistrysupportto...tnetwork.iThembaPharmaceuticalsandPyxisDiscovery,a...
(Date:11/24/2009)...wire/-- ,, WHAT:RomHoubens,aBelgianmanthoughtto...sactuallyfullyconsciousandawakeduringthattimeandwa...EyeMaxwasfeaturedinthesegmenttoillustratehowpeople...mmunication. ,, WHEN:GoodMorningAmerica-- Tuesd....com ,, WHO:RomHoubenswasanengineeringstude...
(Date:11/24/2009)...re-FirstCall/--AnadysPharmaceuticals,Inc.(Nasdaq: ...alPiperJaffrayHealthcareConferenceonTuesday,Decemb...beingheldatTheNewYorkPalaceHotel.SteveWorland,Ph.D...ovideanoverviewofAnadysanditsclinicaldevelopmentpr...tionwillbesimultaneouslywebcastandcanbeaccessedont...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Starpharma Announces 2415 6 million Capital Raising 6366 1Starpharma Announces 2415 6 million Capital Raising 6366 2Starpharma Announces 2415 6 million Capital Raising 6366 3Can EP4 agonist alleviate gastric lesions 3F 61617 1Antifibrotic effects of green tea 61613 1
...Surgery(TM) Platform Product Candidate in Clinical...ay announced,that it is enrolling patients in a Ph... PharmacoSurgery(TM) product candidate, for use du...undergoing age-related,cataract extraction with le...tudy., "With the initiation of this study, all th...
...ing Technology Could Have Widespread Use in Improv...nimals from Extinction, MT. LAUREL, N.J., Sept. 8...with freeze-dried cells is possible for the first,...t issue of the research,journal PLos One. The comp...ed in the study., Cloning starts when an egg with...
Other Medicine Technology:Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302 2New Study Shows Cloning from Dried Cells Now Possible 2
D-Light SR
...proven, highly effective Nd:YAG technology with th...' IPL Quantum series. Its modular and upgradeable ...es to the SR mode for IPL skin treatments using ph...al are also available. Unique multi-synchronized p...
Zoomin'
White-out
Medicine Products: